Intervention

Perhexiline

ClinicalTrials.gov intervention label

Clinical trials6

Recruiting0

Common conditions6

Lead sponsors shown5

Clinical trials

6 shown

Role of Perhexiline in Hypertrophic CardiomyopathyNCT04426578 · 2020-12-01

Open-Label Study of Perhexiline in Patients With Hypertrophic Cardiomyopathy and Moderate to Severe Heart FailureNCT02862600 · 2016-08-01

Perhexiline Therapy in Heart Failure With Preserved Ejection Fraction SyndromeNCT00839228 · 2009-03-01

Metabolic Manipulation in Chronic Heart FailureNCT00841139 · 2009-02-01

Mechanisms Responsible for Cardiac and Skeletal Muscle Energetic Impairment in DiabetesNCT00628056 · 2006-10-01

Efficacy, Safety, and Tolerability of Perhexiline in Subjects With Hypertrophic Cardiomyopathy and Heart FailureNCT02431221

Common conditions

Hypertrophic Cardiomyopathy2 Cardiomyopathy, Hypertrophic1 Cardiomyopathy, Hypertrophic, Familial1 Chronic Heart Failure1 Diabetic Cardiomyopathy1 Diastolic Heart Failure1

Leading sponsors

Heart Metabolics Limited2 Flinders University1 University Hospital Birmingham1 University Hospital Birmingham NHS Foundation Trust1 University of Aberdeen1

Trial status mix

COMPLETED2

UNKNOWN2

TERMINATED1

WITHDRAWN1

Phase mix

PHASE25

PHASE11

PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.